ANTICOAGULATION USE VARIES BY REGION IN PATIENTS WITH RECENT DIAGNOSIS OF ATRIAL FIBRILLATION: GLORIA-AF PHASE III DATA

Bory Kea; Valentina Bayer; Sagar Patel; Peter Larsen; Dana Button; Christine Teutsch; Menno V. Huisman; Professor Gregory Lip; Brian Olshansky

doi:10.1016/s0735-1097(21)02847-3

Related publications

Article2022

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry

Valentina Bayer, Agnieszka Kotalczyk, Bory Kea, Christine Teutsch, Peter Larsen, Dana Button, Menno V. Huisman, Professor Gregory Lip, Brian Olshansky

Article2020

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up

Monika Kozieł, Michał Mazurek, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Changsheng Ma, Kenneth J. Rothman, Axel Brandes, Miney Paquette, Kristina Zint, Lionel Riou França, Shihai Lu, Dorothee B. Bartels, Menno V. Huisman, Professor Gregory Lip

Article2022

Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III

Giulio Francesco Romiti, Marco Proietti, Niccolò Bonini, Wern Yew Ding, Giuseppe Boriani, Menno V. Huisman, Professor Gregory Lip

Article2022

Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III

Giulio Francesco Romiti, Marco Proietti, Niccolò Bonini, Wern Yew Ding, Giuseppe Boriani, Menno V. Huisman, Professor Gregory Lip

Article2025

Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Giuseppe Boriani, Brian Olshansky, Menno V. Huisman, Professor Gregory Lip

ANTICOAGULATION USE VARIES BY REGION IN PATIENTS WITH RECENT DIAGNOSIS OF ATRIAL FIBRILLATION: GLORIA-AF PHASE III DATA

Discussion(0)

Related publications

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up

Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III

Clinical Complexity Domains, Anticoagulation, and Outcomes in Patients with Atrial Fibrillation: A Report from the GLORIA-AF Registry Phase II and III

Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III